Transvaginal Mesh Lawsuit Update: C.R. Bard Transvaginal Mesh Trial Resumes After Mistrial, Notes Hissey Kientz, LLP

Posted on by


Austin, TX (PRWEB) July 31, 2013

The law firm of Hissey Kientz, LLP reports that the first transvaginal mesh bellwether trial against C.R. Bard resumed July 29, 2013 in federal court in West Virginia. According to documents filed in Cisson v. C.R. Bard Inc. (2:11-cv-00195; S.D.W.Va.), plaintiff Donna Cisson alleges that her Avaulta transvaginal mesh implant manufactured by C.R. Bard resulted in injuries such as pain, bleeding and bladder spasms.

U.S. District Judge Joseph R. Goodwin declared the first federal transvaginal mesh trial a mistrial on July 10, 2013 after a gynecological expert witness for Cisson testified about C.R. Bards mesh marketing practices in violation of his earlier ruling on the topic, according to a Bloomberg article from July 10, 2013.

According to the U.S. Food and Drug Administration (FDA), transvaginal mesh implants can cause patients to experience serious complications such as vaginal mesh erosion, mesh migration, organ perforation, severe pain, problems during intercourse, bleeding, infection and urinary problems.

In a Public Health Notification issued on July 13, 2011, the FDA revealed that it had received a total of 3,864 reports of complications involving transvaginal mesh products between 2008 and 2010.

Patients who have experienced vaginal mesh erosion, mesh migration, severe pain, problems during intercourse or bleeding after being implanted with transvaginal mesh may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For a free transvaginal mesh lawsuit consultation, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.


http://www.bloomberg.com/news/2013-07-10/cr-bard-case-over-vaginal-mesh-defects-declared-mistrial.html?cmpid=yhoo

About Hissey Kientz, LLP

Hissey Kientz, LLP (http://www.hkllp.com) represents individuals experiencing complications from transvaginal mesh, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa and Effexor, Medtronic Infuse Bone Grafts, Stryker and BioMet hip replacements, GranuFlo dialysis concentrate and other defective drugs and medical devices.